Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Imiquimod suppresses propagation of herpes simplex virus 1 by upregulation of cystatin A via the adenosine receptor A1 pathway.

Kan Y, Okabayashi T, Yokota S, Yamamoto S, Fujii N, Yamashita T.

J Virol. 2012 Oct;86(19):10338-46. doi: 10.1128/JVI.01196-12. Epub 2012 Jul 11.

3.

TLR7 and TLR8 as targets in cancer therapy.

Schön MP, Schön M.

Oncogene. 2008 Jan 7;27(2):190-9. doi: 10.1038/sj.onc.1210913. Review.

PMID:
18176600
4.

Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.

Gibson SJ, Lindh JM, Riter TR, Gleason RM, Rogers LM, Fuller AE, Oesterich JL, Gorden KB, Qiu X, McKane SW, Noelle RJ, Miller RL, Kedl RM, Fitzgerald-Bocarsly P, Tomai MA, Vasilakos JP.

Cell Immunol. 2002 Jul-Aug;218(1-2):74-86.

PMID:
12470615
5.
6.

The antiviral activity of Toll-like receptor 7 and 7/8 agonists.

Miller RL, Meng TC, Tomai MA.

Drug News Perspect. 2008 Mar;21(2):69-87. Review.

PMID:
18389099
7.

Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?

Urosevic M, Oberholzer PA, Maier T, Hafner J, Laine E, Slade H, Benninghoff B, Burg G, Dummer R.

Clin Cancer Res. 2004 Aug 1;10(15):4959-70.

8.

Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells.

Peri P, Mattila RK, Kantola H, Broberg E, Karttunen HS, Waris M, Vuorinen T, Hukkanen V.

Virol J. 2008 Nov 21;5:140. doi: 10.1186/1743-422X-5-140.

9.
10.

Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses.

Zhang SY, Jouanguy E, Sancho-Shimizu V, von Bernuth H, Yang K, Abel L, Picard C, Puel A, Casanova JL.

Immunol Rev. 2007 Dec;220:225-36. Review.

PMID:
17979850
11.

Toll-like receptor 7-mediated enhancement of contextual fear memory in mice.

Kubo Y, Yanagawa Y, Matsumoto M, Hiraide S, Kobayashi M, Togashi H.

Pharmacol Biochem Behav. 2012 Oct;102(4):495-501. doi: 10.1016/j.pbb.2012.06.017. Epub 2012 Jun 28.

PMID:
22750061
12.
13.

Early innate recognition of herpes simplex virus in human primary macrophages is mediated via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase III-independent pathways.

Melchjorsen J, Rintahaka J, Søby S, Horan KA, Poltajainen A, Østergaard L, Paludan SR, Matikainen S.

J Virol. 2010 Nov;84(21):11350-8. doi: 10.1128/JVI.01106-10. Epub 2010 Aug 25.

14.

Induction of interferon system genes in Atlantic salmon by the imidazoquinoline S-27609, a ligand for Toll-like receptor 7.

Kileng Ø, Albuquerque A, Robertsen B.

Fish Shellfish Immunol. 2008 May;24(5):514-22. doi: 10.1016/j.fsi.2007.10.005. Epub 2007 Oct 25.

PMID:
18337121
15.

Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists.

Butchi NB, Pourciau S, Du M, Morgan TW, Peterson KE.

J Immunol. 2008 Jun 1;180(11):7604-12.

16.

The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.

Vasilakos JP, Tomai MA.

Expert Rev Vaccines. 2013 Jul;12(7):809-19. doi: 10.1586/14760584.2013.811208. Review.

PMID:
23885825
17.

TLR7 is a key regulator of innate immunity against Japanese encephalitis virus infection.

Nazmi A, Mukherjee S, Kundu K, Dutta K, Mahadevan A, Shankar SK, Basu A.

Neurobiol Dis. 2014 Sep;69:235-47. doi: 10.1016/j.nbd.2014.05.036. Epub 2014 Jun 5.

PMID:
24909816
19.

Roles of TLR7 in activation of NF-κB signaling of keratinocytes by imiquimod.

Li ZJ, Sohn KC, Choi DK, Shi G, Hong D, Lee HE, Whang KU, Lee YH, Im M, Lee Y, Seo YJ, Kim CD, Lee JH.

PLoS One. 2013 Oct 11;8(10):e77159. doi: 10.1371/journal.pone.0077159. eCollection 2013.

20.

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells.

Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M.

J Clin Invest. 2012 Feb;122(2):575-85. doi: 10.1172/JCI61034. Epub 2012 Jan 17.

Supplemental Content

Support Center